Market revenue in 2023 | USD 33.0 million |
Market revenue in 2030 | USD 74.9 million |
Growth rate | 12.4% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 52.42% in 2023. Horizon Databook has segmented the UAE structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The United Arab Emirates (UAE) is witnessing a dynamic growth in the structural heart devices market, driven by a combination of factors including the rising prevalence of SHD, advancements in medical technology, and the increasing adoption of minimally invasive procedures. The country's healthcare infrastructure has been significantly enhanced, with a focus on early detection and treatment of SHD.
This has facilitated the adoption of advanced cardiovascular care technologies, including structural heart devices. The growing awareness and adoption of these technologies are further supported by favorable reimbursement scenarios for structural heart procedures and devices, as well as regulatory approvals for new and advanced structural heart devices.
TAVI is a notable trend within the structural heart devices market in the UAE. TAVI is a minimally invasive procedure that involves the implantation of a new aortic valve through a catheter, without the need for open-heart surgery.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into UAE structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account